Cara Therapeutics, Inc. (CARA): Price and Financial Metrics


Cara Therapeutics, Inc. (CARA)

Today's Latest Price: $15.37 USD

0.25 (-1.60%)

Updated Jun 5 4:00pm

Add CARA to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 336 in Biotech

See all "A" rated Strong Buy stocks

CARA Stock Summary

  • Of note is the ratio of Cara Therapeutics Inc's sales and general administrative expense to its total operating expenses; only 6.21% of US stocks have a lower such ratio.
  • The ratio of debt to operating expenses for Cara Therapeutics Inc is higher than it is for about just 6.9% of US stocks.
  • With a price/sales ratio of 30.48, Cara Therapeutics Inc has a higher such ratio than 95.15% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Cara Therapeutics Inc, a group of peers worth examining would be ANAB, MGNX, VBLT, WVE, and CRBP.
  • CARA's SEC filings can be seen here. And to visit Cara Therapeutics Inc's official web site, go to www.caratherapeutics.com.
CARA Daily Price Range
CARA 52-Week Price Range

CARA Stock Price Chart More Charts


CARA Price/Volume Stats

Current price $15.37 52-week high $27.55
Prev. close $15.62 52-week low $8.88
Day low $15.35 Volume 522,444
Day high $16.15 Avg. volume 552,922
50-day MA $14.81 Dividend yield N/A
200-day MA $17.51 Market Cap 719.25M

Cara Therapeutics, Inc. (CARA) Company Bio


Cara Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors. The company was founded in 2004 and is based in Shelton, Connecticut.


CARA Latest News Stream


Event/TimeNews Detail
Loading, please wait...

CARA Latest Social Stream


Loading social stream, please wait...

View Full CARA Social Stream

Latest CARA News From Around the Web

Below are the latest news stories about Cara Therapeutics Inc that investors may wish to consider to help them evaluate CARA as an investment opportunity.

Top Marijuana Stocks on the NASDAQ for June 2020

These are the NASDAQ-listed marijuana stocks with the best value, fastest growth, and most momentum for June.

Yahoo | May 28, 2020

Cara Therapeutics to Present at the Jefferies Virtual Healthcare Conference

STAMFORD, Conn., May 27, 2020 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and…

GlobeNewswire | May 27, 2020

Is Cara Therapeutics (CARA) Stock a Solid Choice Right Now?

Cara Therapeutics (CARA) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Zacks Investment Research | May 15, 2020

Edited Transcript of CARA earnings conference call or presentation 11-May-20 8:30pm GMT

Q1 2020 Cara Therapeutics Inc Earnings Call

Yahoo | May 12, 2020

Cara Therapeutics Inc (CARA) Q1 2020 Earnings Call Transcript

This is Jack Hildick-Smith with Stern Investor Relations and welcome to Cara Therapeutics' first quarter 2020 financial results and update conference call. Before we begin, let me remind you that statements made on today's call regarding matters that are not historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Examples of these forward-looking statements, include statements concerning the expected timing of the data readouts from the Company's ongoing clinical trials, the potential results of ongoing clinical trials, timing of future regulatory and development milestones for the Company's product candidates, including the Company's projected timeline for the submission of its first NDA, the potential for the Compan...

Yahoo | May 12, 2020

Read More 'CARA' Stories Here

CARA Price Returns

1-mo 4.13%
3-mo 0.59%
6-mo -5.47%
1-year -23.30%
3-year -11.87%
5-year 54.63%
YTD -4.59%
2019 23.92%
2018 6.21%
2017 31.75%
2016 -44.90%
2015 69.11%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 1.0288 seconds.